Regeneron requests emergency approval for antibody treatment taken by Trump; stock rises 4% in pre-market
October 08, 2020 at 06:16 AM EDT
Regeneron's stock price rose over 4% in pre-market trade Thursday.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|